Elevated interleukin-6 secretion levels by mononuclear cells of Alzheimer's patients

F. Shalit; B. Sredni; L. Stern; E. Kott; M. Huberman

doi:10.1016/0304-3940(94)90003-5

Elevated interleukin-6 secretion levels by mononuclear cells of Alzheimer's patients

F. Shalit
, B. Sredni
, L. Stern
, E. Kott
, M. Huberman

Research output: Contribution to journal › Article › peer-review

51 Scopus citations

Abstract

It has been suggested in recent research that interleukin-1 (IL-1) and interleukin-6 (IL-6) play a role in the pathogenesis of Alzheimer's disease (AD). Production of IL-1, by lipopolysaccharide (LPS)-stimulated monocytes, and IL-6, by phytohaemagglutinin (PHA)-stimulated mononuclear cells, was assessed in patients with AD divided into two groups - mild and moderately severe -according to severity of disease, and elderly controls. No differences in IL-1 production were found among AD patients and controls. However, significant elevation in IL-6 secretion levels was observed in both the mild and moderately severe AD patients. Our results suggest that peripheral IL-6 secretion levels may be responsible for acute-phase proteins observed in the serum of AD patients.

Original language	English
Pages (from-to)	130-132
Number of pages	3
Journal	Neuroscience Letters
Volume	174
Issue number	2
DOIs	https://doi.org/10.1016/0304-3940(94)90003-5
State	Published - 20 Jun 1994

Keywords

Acute-phase protein
Alzheimer's Disease
Cytokine
Dementia
Interleukin-1
Interleukin-6

Access to Document

10.1016/0304-3940(94)90003-5

Cite this

@article{9b498744d34c410181dfdb2d4fa14f93,

title = "Elevated interleukin-6 secretion levels by mononuclear cells of Alzheimer's patients",

abstract = "It has been suggested in recent research that interleukin-1 (IL-1) and interleukin-6 (IL-6) play a role in the pathogenesis of Alzheimer's disease (AD). Production of IL-1, by lipopolysaccharide (LPS)-stimulated monocytes, and IL-6, by phytohaemagglutinin (PHA)-stimulated mononuclear cells, was assessed in patients with AD divided into two groups - mild and moderately severe -according to severity of disease, and elderly controls. No differences in IL-1 production were found among AD patients and controls. However, significant elevation in IL-6 secretion levels was observed in both the mild and moderately severe AD patients. Our results suggest that peripheral IL-6 secretion levels may be responsible for acute-phase proteins observed in the serum of AD patients.",

keywords = "Acute-phase protein, Alzheimer's Disease, Cytokine, Dementia, Interleukin-1, Interleukin-6",

author = "F. Shalit and B. Sredni and L. Stern and E. Kott and M. Huberman",

year = "1994",

month = jun,

day = "20",

doi = "10.1016/0304-3940(94)90003-5",

language = "אנגלית",

volume = "174",

pages = "130--132",

journal = "Neuroscience Letters",

issn = "0304-3940",

publisher = "Elsevier Ireland Ltd",

number = "2",

}

TY - JOUR

T1 - Elevated interleukin-6 secretion levels by mononuclear cells of Alzheimer's patients

AU - Shalit, F.

AU - Sredni, B.

AU - Stern, L.

AU - Kott, E.

AU - Huberman, M.

PY - 1994/6/20

Y1 - 1994/6/20

N2 - It has been suggested in recent research that interleukin-1 (IL-1) and interleukin-6 (IL-6) play a role in the pathogenesis of Alzheimer's disease (AD). Production of IL-1, by lipopolysaccharide (LPS)-stimulated monocytes, and IL-6, by phytohaemagglutinin (PHA)-stimulated mononuclear cells, was assessed in patients with AD divided into two groups - mild and moderately severe -according to severity of disease, and elderly controls. No differences in IL-1 production were found among AD patients and controls. However, significant elevation in IL-6 secretion levels was observed in both the mild and moderately severe AD patients. Our results suggest that peripheral IL-6 secretion levels may be responsible for acute-phase proteins observed in the serum of AD patients.

AB - It has been suggested in recent research that interleukin-1 (IL-1) and interleukin-6 (IL-6) play a role in the pathogenesis of Alzheimer's disease (AD). Production of IL-1, by lipopolysaccharide (LPS)-stimulated monocytes, and IL-6, by phytohaemagglutinin (PHA)-stimulated mononuclear cells, was assessed in patients with AD divided into two groups - mild and moderately severe -according to severity of disease, and elderly controls. No differences in IL-1 production were found among AD patients and controls. However, significant elevation in IL-6 secretion levels was observed in both the mild and moderately severe AD patients. Our results suggest that peripheral IL-6 secretion levels may be responsible for acute-phase proteins observed in the serum of AD patients.

KW - Acute-phase protein

KW - Alzheimer's Disease

KW - Cytokine

KW - Dementia

KW - Interleukin-1

KW - Interleukin-6

UR - https://www.scopus.com/pages/publications/0028341702

U2 - 10.1016/0304-3940(94)90003-5

DO - 10.1016/0304-3940(94)90003-5

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

C2 - 7970167

AN - SCOPUS:0028341702

SN - 0304-3940

VL - 174

SP - 130

EP - 132

JO - Neuroscience Letters

JF - Neuroscience Letters

IS - 2

ER -

Elevated interleukin-6 secretion levels by mononuclear cells of Alzheimer's patients

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this